About 12 months ago, AbbVie filed a Citizen Petition asking the FDA to take certain steps to tighten and clarify its procedures for making interchangeability determinations. Earlier this year, both Sandoz and GPhA urged the FDA to deny the petition. Today, the FDA posted an interim response on the docket (FDA-2015-P-4935)…